Bopeptide Biotechnology
Tirzepatide
Finnrick tested 4 samples of Tirzepatide (GLP-1 and GIP agonist) from Bopeptide Biotechnology between 31 Jul 2025 and 15 Jan 2026. Test scores average over 5, no score below 4, and at least 2 tests warrant a tentative Finnrick Rating of C (Okay).
Finnrick Rating™
Tentative Rating
Bopeptide Biotechnology
Tirzepatide
Tested 4 Samples
Last test 15 Jan 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Tirzepatide tests from top-rated vendors:
All Tirzepatide tests from Bopeptide Biotechnology
Samples are tested in commercial labs
Tests Count
4
Scores
AVGMINMAX
Last
15 Jan 2026
First
31 Jul 2025
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 15 Jan 2026 | View | 30mg | 39.4mg | +31.3% | 99.80% | n/a | (no batch ID) | No Label / Silver Crimp / Black Cap | Lab G | Public | |
| 9 Jan 2026 | View | 30mg | 28.6mg | -4.7% | 99.95% | below LOQ | 85266799413 | No Label / Silver Crimp / Orange Cap | Lab E | Public | |
| 10 Sep 2025 | View | 5mg | 5.33mg | +6.6% | 99.95% | n/a | (no batch ID) | No Label / Silver Crimp / Black Cap | Lab E | Public | |
| 31 Jul 2025 | View | 10mg | 10.95mg | +9.5% | 98.90% | n/a | (no batch ID) | No Label / Silver Crimp / Yellow Cap | Lab A | Public | |